降钙素原
医学
心房颤动
心脏外科
中心静脉压
内科学
心脏病学
利钠肽
血压
麻醉
心率
心力衰竭
败血症
作者
Zhiwei Xu,Long Qian,Lijuan Zhang,Guangli Yang,Heng Su
出处
期刊:PubMed
[National Institutes of Health]
日期:2022-01-01
卷期号:14 (5): 3481-3487
被引量:1
摘要
To investigate the predictive value of N-terminal pro brain natriuretic peptide (NT-proBNP), procalcitonin and central venous pressure (CVP) for new atrial fibrillation after cardiac surgery.Patients underwent cardiac surgery in Huai'an First People's Hospital from June 2019 to December 2020 were enrolled in this study. Patients without POAF after surgery were included in the control group, and patients with POAF after surgery were included in the POAF group. Clinical data of patients were collected and retrospectively analyzed.The incidence of in-hospital complications, length of stay and cost of hospitalization in the POAF group were significantly higher than those in the control group; Moreover, there were significant differences in central venous pressure, peak cTnI, NT-proBNP, procalcitonin, and white blood cell counts between the two groups. NT-proBNP, procalcitonin and elevated central venous pressure are independent risk factors for POAF in patients after cardiac surgery.NT-proBNP, procalcitonin and CVP were closely related with atrial fibrillation after cardiac surgery. The combination of NT-proBNP, procalcitonin and CVP had a better discriminative ability for new atrial fibrillation after cardiac surgery compared to either of them alone.
科研通智能强力驱动
Strongly Powered by AbleSci AI